X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
50
PharmaCompass offers a list of Budesonide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Budesonide manufacturer or Budesonide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Budesonide manufacturer or Budesonide supplier.
PharmaCompass also assists you with knowing the Budesonide API Price utilized in the formulation of products. Budesonide API Price is not always fixed or binding as the Budesonide Price is obtained through a variety of data sources. The Budesonide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Symbicort manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Symbicort, including repackagers and relabelers. The FDA regulates Symbicort manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Symbicort API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Symbicort manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Symbicort supplier is an individual or a company that provides Symbicort active pharmaceutical ingredient (API) or Symbicort finished formulations upon request. The Symbicort suppliers may include Symbicort API manufacturers, exporters, distributors and traders.
click here to find a list of Symbicort suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Symbicort DMF (Drug Master File) is a document detailing the whole manufacturing process of Symbicort active pharmaceutical ingredient (API) in detail. Different forms of Symbicort DMFs exist exist since differing nations have different regulations, such as Symbicort USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Symbicort DMF submitted to regulatory agencies in the US is known as a USDMF. Symbicort USDMF includes data on Symbicort's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Symbicort USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Symbicort suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Symbicort Drug Master File in Japan (Symbicort JDMF) empowers Symbicort API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Symbicort JDMF during the approval evaluation for pharmaceutical products. At the time of Symbicort JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Symbicort suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Symbicort Drug Master File in Korea (Symbicort KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Symbicort. The MFDS reviews the Symbicort KDMF as part of the drug registration process and uses the information provided in the Symbicort KDMF to evaluate the safety and efficacy of the drug.
After submitting a Symbicort KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Symbicort API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Symbicort suppliers with KDMF on PharmaCompass.
A Symbicort CEP of the European Pharmacopoeia monograph is often referred to as a Symbicort Certificate of Suitability (COS). The purpose of a Symbicort CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Symbicort EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Symbicort to their clients by showing that a Symbicort CEP has been issued for it. The manufacturer submits a Symbicort CEP (COS) as part of the market authorization procedure, and it takes on the role of a Symbicort CEP holder for the record. Additionally, the data presented in the Symbicort CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Symbicort DMF.
A Symbicort CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Symbicort CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Symbicort suppliers with CEP (COS) on PharmaCompass.
A Symbicort written confirmation (Symbicort WC) is an official document issued by a regulatory agency to a Symbicort manufacturer, verifying that the manufacturing facility of a Symbicort active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Symbicort APIs or Symbicort finished pharmaceutical products to another nation, regulatory agencies frequently require a Symbicort WC (written confirmation) as part of the regulatory process.
click here to find a list of Symbicort suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Symbicort as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Symbicort API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Symbicort as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Symbicort and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Symbicort NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Symbicort suppliers with NDC on PharmaCompass.
Symbicort Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Symbicort GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Symbicort GMP manufacturer or Symbicort GMP API supplier for your needs.
A Symbicort CoA (Certificate of Analysis) is a formal document that attests to Symbicort's compliance with Symbicort specifications and serves as a tool for batch-level quality control.
Symbicort CoA mostly includes findings from lab analyses of a specific batch. For each Symbicort CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Symbicort may be tested according to a variety of international standards, such as European Pharmacopoeia (Symbicort EP), Symbicort JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Symbicort USP).
Market Place
